The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis

Abstract Background Two studies were conducted to determine whether treatment with NexGard® Plus (NP), a combination of afoxolaner, moxidectin, and pyrantel, prevents transmission of Borrelia burgdorferi to dogs by naturally infected Ixodes scapularis. Methods For each study, 20 dogs were randomly a...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Prullage, Pascal Dumont, Arathy Nair, Manyun Liu, Utami DiCosty, Ricarda Süssenberger
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/s13071-025-06753-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172951968612352
author Joseph Prullage
Pascal Dumont
Arathy Nair
Manyun Liu
Utami DiCosty
Ricarda Süssenberger
author_facet Joseph Prullage
Pascal Dumont
Arathy Nair
Manyun Liu
Utami DiCosty
Ricarda Süssenberger
author_sort Joseph Prullage
collection DOAJ
description Abstract Background Two studies were conducted to determine whether treatment with NexGard® Plus (NP), a combination of afoxolaner, moxidectin, and pyrantel, prevents transmission of Borrelia burgdorferi to dogs by naturally infected Ixodes scapularis. Methods For each study, 20 dogs were randomly assigned to two groups (n = 10/group): NP and negative control. Twenty-eight days post-treatment, each dog was infested with approximately 50 I. scapularis that had a 60% B. burgdorferi infection rate in study 1 and a 38.5% infection rate in study 2. Five days post-infestation, ticks were counted and removed. The B. burgdorferi-specific C6 antibody was tested for using the SNAP® 4Dx® test (IDEXX) and the Lyme Quant C6 test with serum collected before treatment and infestation and 21, 35, 49, 63, and 75 days post-infestation. Skin biopsies were collected 76 days post-infestation and quantitative polymerase chain reaction (qPCR) conducted to detect B. burgdorferi DNA. Results On the day of count and removal, no ticks were found on treated dogs, while control dogs had an average of 25.1 ticks in study 1 and 19.6 ticks in study 2, for efficacy of 100% (P ≤ 0.0001). All dogs were seronegative before infestation. The first dog in the control groups became seropositive 21 days post-infestation in study 1 and 35 days post-infestation in study 2 by the SNAP 4Dx test and by 21 days post-infestation by the Lyme Quant C6 test in both studies. Ten of 10 dogs in the control group in both studies seroconverted by the end of the study. None of the skin biopsies from treated dogs were positive for B. burgdorferi DNA, while at least three of the four skin biopsies from each of the control dogs tested positive at the end of the studies. No clinical signs of Lyme disease were detected in any of the dogs. Conclusions The results of these studies indicate that NexGard® Plus administered at a dose close to the minimum recommended dose of 2.5 mg/kg afoxolaner is effective 28 days after a single treatment in the prevention of B. burgdorferi transmission from naturally infected I. scapularis ticks to dogs. Graphical Abstract
format Article
id doaj-art-e3b617b181594f66a073aafacda9fde3
institution OA Journals
issn 1756-3305
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj-art-e3b617b181594f66a073aafacda9fde32025-08-20T02:19:57ZengBMCParasites & Vectors1756-33052025-04-011811510.1186/s13071-025-06753-8The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularisJoseph Prullage0Pascal Dumont1Arathy Nair2Manyun Liu3Utami DiCosty4Ricarda Süssenberger5Boehringer Ingelheim Animal Health, Missouri Research CenterBoehringer Ingelheim Animal Health, Georgia Research CenterBoehringer Ingelheim Animal Health, Georgia Research CenterBoehringer Ingelheim Animal Health, Georgia Research CenterTRS Labs, Inc.Boehringer Ingelheim Vetmedica GmbHAbstract Background Two studies were conducted to determine whether treatment with NexGard® Plus (NP), a combination of afoxolaner, moxidectin, and pyrantel, prevents transmission of Borrelia burgdorferi to dogs by naturally infected Ixodes scapularis. Methods For each study, 20 dogs were randomly assigned to two groups (n = 10/group): NP and negative control. Twenty-eight days post-treatment, each dog was infested with approximately 50 I. scapularis that had a 60% B. burgdorferi infection rate in study 1 and a 38.5% infection rate in study 2. Five days post-infestation, ticks were counted and removed. The B. burgdorferi-specific C6 antibody was tested for using the SNAP® 4Dx® test (IDEXX) and the Lyme Quant C6 test with serum collected before treatment and infestation and 21, 35, 49, 63, and 75 days post-infestation. Skin biopsies were collected 76 days post-infestation and quantitative polymerase chain reaction (qPCR) conducted to detect B. burgdorferi DNA. Results On the day of count and removal, no ticks were found on treated dogs, while control dogs had an average of 25.1 ticks in study 1 and 19.6 ticks in study 2, for efficacy of 100% (P ≤ 0.0001). All dogs were seronegative before infestation. The first dog in the control groups became seropositive 21 days post-infestation in study 1 and 35 days post-infestation in study 2 by the SNAP 4Dx test and by 21 days post-infestation by the Lyme Quant C6 test in both studies. Ten of 10 dogs in the control group in both studies seroconverted by the end of the study. None of the skin biopsies from treated dogs were positive for B. burgdorferi DNA, while at least three of the four skin biopsies from each of the control dogs tested positive at the end of the studies. No clinical signs of Lyme disease were detected in any of the dogs. Conclusions The results of these studies indicate that NexGard® Plus administered at a dose close to the minimum recommended dose of 2.5 mg/kg afoxolaner is effective 28 days after a single treatment in the prevention of B. burgdorferi transmission from naturally infected I. scapularis ticks to dogs. Graphical Abstracthttps://doi.org/10.1186/s13071-025-06753-8CanineBorrelia burgdorferiIxodes scapularisPreventionLyme borreliosisTransmission
spellingShingle Joseph Prullage
Pascal Dumont
Arathy Nair
Manyun Liu
Utami DiCosty
Ricarda Süssenberger
The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
Parasites & Vectors
Canine
Borrelia burgdorferi
Ixodes scapularis
Prevention
Lyme borreliosis
Transmission
title The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
title_full The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
title_fullStr The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
title_full_unstemmed The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
title_short The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis
title_sort ability of an oral combination of afoxolaner moxidectin and pyrantel to protect dogs from borrelia burgdorferi infections transmitted by ixodes scapularis
topic Canine
Borrelia burgdorferi
Ixodes scapularis
Prevention
Lyme borreliosis
Transmission
url https://doi.org/10.1186/s13071-025-06753-8
work_keys_str_mv AT josephprullage theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT pascaldumont theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT arathynair theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT manyunliu theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT utamidicosty theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT ricardasussenberger theabilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT josephprullage abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT pascaldumont abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT arathynair abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT manyunliu abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT utamidicosty abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis
AT ricardasussenberger abilityofanoralcombinationofafoxolanermoxidectinandpyranteltoprotectdogsfromborreliaburgdorferiinfectionstransmittedbyixodesscapularis